Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @envisagenics
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @envisagenics
-
Envisagenics proslijedio/la je Tweet
This
#WorldCancerDay
, we celebrate the power of #collaboration!

The crucial knowledge obtained by this CSHL and @sloan_kettering team-up paves a fresh path towards the potential development of new#BloodCancer treatment options: http://bit.ly/36UtZQx pic.twitter.com/4nRxWgbLlzMutation’s role in blood cancers revealed by ideal collaborationHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics is growing its Business Development team! If you have experience building B2B Bio-Pharma relationships and generating transactional revenue, we would love to hear from you. Please apply here:https://www.glassdoor.com/job-listing/business-development-associate-envisagenics-JV_IC1132348_KO0,30_KE31,43.htm?jl=3479733053&utm_medium=email&utm_source=sharejob&utm_campaign=sj-email&utm_content=sharejob-email-sharedJob&utm_term= …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
Congratulations to Alinoor (Mohamad) Rahman and Adrian Krainer for the new paper out today in
@GenesDev on the effect of RNA splicing factor mutations on nonsense mediated RNA decay (NMD). A very elegant study on how altered splicing impacts NMD: http://genesdev.cshlp.org/content/early/2020/01/28/gad.332270.119.abstract …pic.twitter.com/rbDitLFzP9
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
Two of our favorite collaborators in the
#nyc#biotech community! If you're interested in working at Envisagenics, or any of the other great companies based in and around New York, definitely submit an application to the LifeSci NYC internship program. Deadline is 3/31!https://twitter.com/envisagenics/status/1220066659328843779 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics is once again accepting internship applications through its partner,
@LfSciNYCInterns, for Data Science and Bioinformatics tracks. If you're motivated to discover cures, and you're up for the challenge, please apply!http://bit.ly/lifescistudentsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
Last talk of day at
#PgDaySF,@therealansonism of@envisagenics is giving a crash course in Omics data before explaining why an RDBMS like#PostgreSQL can be so useful for therapeutic AI apps. One question: should there be FDW for FASTQ files?pic.twitter.com/AVqyla69LD – mjesto: Swedish American Hall
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
“Our goal is to harness all of today’s knowledge & tools to deliver solutions that prevent, intercept & cure disease... and to ensure that those solutions reach everyone, everywhere. Connect with
#JNJ#CSO Paul Stoffels this week at#JPM20.pic.twitter.com/WyXIjwsszvHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
The Impact of AI session was standing room only! Great session at
#BiotechShowcase.@theaaih@ron_alfa@RecursionPharma@JNJNews@zavaindar@Lux_Capital@rafecooks@Genialis@HVHPrecision@hannahkuchler@FT#DigiMedShow#BiotechShowcasepic.twitter.com/mcUkzWvkry
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Only more excitement in the
#ASO field! From@ionis Stanley and Rosanne Crooke stay focused on anti-sense, stealing back patients from disease with N-of-1 tech - https://endpts.com/stanley-and-rosanne-crooke-stay-focused-on-anti-sense-stealing-back-patients-from-disease-with-n-of-1-tech/ …#RNA#splicing#drugdiscoveryHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
The
#entrepreneurs we invest in are building the next generation of tech, spanning#bigdata and#analytics, business SaaS,#cloud infrastructure,#AI /#ML, productivity, security & emerging technologies. Learn more on the innovators in our portfolio: https://m12.vc/companies/ pic.twitter.com/OOY7hsvB1z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
What does it mean to be an
#innovator and#entrepreneur? Check out this video to hear what@envisagenics CTO & cofounder@makerman30 has to say.@LeadersIn@BiotechWkBoston#startup#biotechhttps://www.youtube.com/watch?v=jRfi9M-UPig&feature=youtu.be …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Feliz Navidad
& Hanukkah Sameach
! From @envisagenics team and family to all of yours!#startup#holidayparty#December2019pic.twitter.com/CcTSHxKmix – mjesto: Greenwich Street Tavern
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
On Dec 16, Schrödinger Chief Biomedical Scientist Dr. Karen Akinsanya will share her perspective on the business of building a computational drug discovery company with the
#NYAGIM community. More information on the event can be found here: https://bit.ly/35Cuuyc pic.twitter.com/rnCmtdCtea
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
Attendees flock to the third poster session and reception. Topics: Tumor Cell and Molecular Biology, Prognostic and Predictive Factors, Treatment, and Ongoing Trials.
#SABCS19pic.twitter.com/YpOMp1mREl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Stop by today 5pm poster session3
@SABCSSanAntonio To learn how we ID & characterize novel splice variants in triple-negative breast cancer by our VP of Bio@gayatriarun P2-11-21#SABCS2019#AI#RNAseq#NucleicAcidTherapeutics#splicing#breastcancer#drugdiscovery@CSHL@JLABSHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
Great work from
@OlgaAnczukow on the different roles of splicing factors in breast cancer!https://twitter.com/OlgaAnczukow/status/1199458631302795265 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
JAX's @OlgaAnczukow and colleagues@uconnhealth &@CSHL were curious about whether splicing factors could be responsible for the way#breastcancer grows and spreads.
This new study is out now in @CellReports:https://www.jax.org/news-and-insights/2019/december/exploring-the-role-of-gene-splicing-in-triple-negative-breast-cancer …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
#GoodwinLaw hosts New York Area Group for Informatics & Modeling on Mon, Dec 16th for a discussion of building a drug discovery company with a computational platform w/@envisagenics CEO & Chief Biomed Scientist@Schrodinger For more info and to register:http://ow.ly/sk7j50xs2xmHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#futurepharma@theaaih cofounders and leaders of the#AIML in#drugdiscovery market@Angeli_Moeller@allg00d@NaheedKurji@biogerontology@ron_alfa@ar_shabani@makerman30pic.twitter.com/pqKjM66LEa – mjesto: Congress Center Basel
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Envisagenics proslijedio/la je Tweet
What a lively discussion by our
#AI in R&D panel from@Numerate_Inc@InSilicoMeds@cyclica@RecursionPharma@qulab_inc@envisagenics#BioDataCongresspic.twitter.com/fZ2kdtGUxG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.